Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC).
N. Harbeck
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
M. Kaufmann
No relevant relationships to disclose
F. Siedentopf
Honoraria - Roche
P. Dalivoust
No relevant relationships to disclose
M. Debled
No relevant relationships to disclose
N. J. Robert
Consultant or Advisory Role - Pfizer; Roche; Sanofi
Honoraria - Roche; Sanofi
Research Funding - Pfizer
J. O'Shaughnessy
Consultant or Advisory Role - Roche
Honoraria - Roche